BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15967651)

  • 1. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization.
    Souto C; Rodríguez A; Parajes S; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):94-9. PubMed ID: 15967651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
    Rojas J; Guisao S; Ruge V
    AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of benznidazole pellets for immediate drug delivery using the extrusion spheronization technique.
    Alves-Silva I; Marreto RN; Gelfuso GM; Sá-Barreto LC; Lima EM; Cunha-Filho MS
    Drug Dev Ind Pharm; 2017 May; 43(5):762-769. PubMed ID: 27487264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets.
    Goyanes A; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2011 Jul; 37(7):825-31. PubMed ID: 21405942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
    Balaxi M; Nikolakakis I; Kachrimanis K; Malamataris S
    J Pharm Sci; 2009 Feb; 98(2):676-89. PubMed ID: 18548618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation.
    Afrasiabi Garekani H; Aftabi SF; Nia FF; Javidi M; Nokhodchi A; Sadeghi F
    Pharm Dev Technol; 2019 Jul; 24(6):720-728. PubMed ID: 30776937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Int J Pharm; 2020 Mar; 577():119080. PubMed ID: 31988030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area.
    Iwao Y; Tanaka S; Uchimoto T; Noguchi S; Itai S
    Int J Pharm; 2013 May; 448(1):1-8. PubMed ID: 23518366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of ethanol on superdisintegrants and on tablets disintegration.
    Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
    Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.
    Meruva S; Thool P; Gong Y; Karki S; Bowen W; Kumar S
    Int J Pharm; 2020 Mar; 577():119026. PubMed ID: 31940456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets.
    Pavloková S; Muselík J; Sabadková D; Bernatová S; Samek O; Neumann D; Franc A
    Eur J Pharm Sci; 2019 Apr; 132():86-95. PubMed ID: 30825510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.
    Kilor VA; Sapkal NP; Awari JG; Shewale BD
    AAPS PharmSciTech; 2010 Mar; 11(1):336-43. PubMed ID: 20195805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.